Zenlabs Ethica Share Price
Sector: Major Drugs
32.84 +0.04 (0.12%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
31.85
Today’s High
32.99
52 Week Low
27.33
52 Week High
52.10
Key Metrics
- Market Cap (In Cr) 21.38
- Beta 0.03
- Div. Yield (%) 0
- P/B 2.05
- TTM P/E 45.9
- Peg Ratio -1.54
- Sector P/E 0
- D/E 0.01
- Open Price 32
- Prev Close 32.8
Zenlabs Ethica Analysis
Price Analysis
-
1 Week4.53%
-
3 Months-2.53%
-
6 Month-17.94%
-
YTD-16.48%
-
1 Year-25.45%
Risk Meter
- 44% Low risk
- 44% Moderate risk
- 44% Balanced Risk
- 44% High risk
- 44% Extreme risk
Zenlabs Ethica Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 51.42
- Selling/ General/ Admin Expenses Total
- 4.2
- Depreciation/ Amortization
- 1.26
- Other Operating Expenses Total
- 7.43
- Total Operating Expense
- 50.12
- Operating Income
- 1.31
- Net Income Before Taxes
- 0.43
- Net Income
- 0.27
- Diluted Normalized EPS
- 0.41
- Period
- 2025
- Total Assets
- 40.62
- Total Liabilities
- 30.2
- Total Equity
- 10.43
- Tangible Book Valueper Share Common Eq
- 16.01
- Period
- 2025
- Cashfrom Operating Activities
- 3.83
- Cashfrom Investing Activities
- 0.14
- Cashfrom Financing Activities
- -3.08
- Net Changein Cash
- 0.88
- Period
- 2024
- Total Revenue
- 58.56
- Selling/ General/ Admin Expenses Total
- 4.46
- Depreciation/ Amortization
- 1.29
- Other Operating Expenses Total
- 7.91
- Total Operating Expense
- 57.45
- Operating Income
- 1.12
- Net Income Before Taxes
- 0.58
- Net Income
- 0.42
- Diluted Normalized EPS
- 0.65
- Period
- 2024
- Total Assets
- 40.26
- Total Liabilities
- 30.14
- Total Equity
- 10.12
- Tangible Book Valueper Share Common Eq
- 15.55
- Period
- 2024
- Cashfrom Operating Activities
- -9.06
- Cashfrom Investing Activities
- 0.11
- Cashfrom Financing Activities
- 8.24
- Net Changein Cash
- -0.71
- Period
- 2023
- Total Revenue
- 66.89
- Selling/ General/ Admin Expenses Total
- 4.33
- Depreciation/ Amortization
- 1.25
- Other Operating Expenses Total
- 6.35
- Total Operating Expense
- 65.81
- Operating Income
- 1.08
- Net Income Before Taxes
- 0.67
- Net Income
- 0.49
- Diluted Normalized EPS
- 1.39
- Period
- 2023
- Total Assets
- 43.49
- Total Liabilities
- 33.79
- Total Equity
- 9.7
- Tangible Book Valueper Share Common Eq
- 14.91
- Period
- 2023
- Cashfrom Operating Activities
- 1.52
- Cashfrom Investing Activities
- -1.47
- Cashfrom Financing Activities
- 0.06
- Net Changein Cash
- 0.11
- Period
- 2022
- Total Revenue
- 69.09
- Selling/ General/ Admin Expenses Total
- 3.9
- Depreciation/ Amortization
- 0.89
- Other Operating Expenses Total
- 6.36
- Total Operating Expense
- 67.54
- Operating Income
- 1.55
- Net Income Before Taxes
- 1.26
- Net Income
- 0.82
- Diluted Normalized EPS
- 1.26
- Period
- 2022
- Total Assets
- 37.9
- Total Liabilities
- 28.56
- Total Equity
- 9.33
- Tangible Book Valueper Share Common Eq
- 14.34
- Period
- 2022
- Cashfrom Operating Activities
- -0.38
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- 0.31
- Net Changein Cash
- -0.06
- Period
- 2021
- Total Revenue
- 56.64
- Selling/ General/ Admin Expenses Total
- 3.35
- Depreciation/ Amortization
- 0.27
- Other Operating Expenses Total
- 5.43
- Total Operating Expense
- 55.79
- Operating Income
- 0.85
- Net Income Before Taxes
- 0.92
- Net Income
- 0.83
- Diluted Normalized EPS
- 1.3
- Period
- 2021
- Total Assets
- 32.11
- Total Liabilities
- 23.69
- Total Equity
- 8.42
- Tangible Book Valueper Share Common Eq
- 12.93
- Period
- 2021
- Cashfrom Operating Activities
- 0.16
- Cashfrom Investing Activities
- -0.46
- Cashfrom Financing Activities
- -0.13
- Net Changein Cash
- -0.43
- Period
- 2020
- Total Revenue
- 59.95
- Selling/ General/ Admin Expenses Total
- 3.97
- Depreciation/ Amortization
- 0.29
- Other Operating Expenses Total
- 7.37
- Total Operating Expense
- 61.09
- Operating Income
- -1.14
- Net Income Before Taxes
- -1.17
- Net Income
- -0.73
- Diluted Normalized EPS
- -1.13
- Period
- 2020
- Total Assets
- 33.99
- Total Liabilities
- 26.58
- Total Equity
- 7.41
- Tangible Book Valueper Share Common Eq
- 11.38
- Period
- 2020
- Cashfrom Operating Activities
- 0.45
- Cashfrom Investing Activities
- 0.01
- Cashfrom Financing Activities
- -0.03
- Net Changein Cash
- 0.43
- Period
- 2019
- Total Revenue
- 67.3
- Selling/ General/ Admin Expenses Total
- 3.28
- Depreciation/ Amortization
- 0.23
- Other Operating Expenses Total
- 9.92
- Total Operating Expense
- 65.43
- Operating Income
- 1.86
- Net Income Before Taxes
- 1.89
- Net Income
- 1.26
- Diluted Normalized EPS
- 2
- Period
- 2019
- Total Assets
- 34.89
- Total Liabilities
- 26.62
- Total Equity
- 8.28
- Tangible Book Valueper Share Common Eq
- 12.71
- Period
- 2019
- Cashfrom Operating Activities
- 0.8
- Cashfrom Investing Activities
- -0.22
- Cashfrom Financing Activities
- -0.14
- Net Changein Cash
- 0.44
- Period
- 2025-03-31
- Total Revenue
- 12.99
- Selling/ General/ Admin Expenses Total
- 1.04
- Depreciation/ Amortization
- 0.31
- Other Operating Expenses Total
- 2.59
- Total Operating Expense
- 12.64
- Operating Income
- 0.34
- Net Income Before Taxes
- 0.16
- Net Income
- 0.09
- Diluted Normalized EPS
- 0.41
- Period
- 2025-03-31
- Total Assets
- 40.62
- Total Liabilities
- 30.2
- Total Equity
- 10.43
- Tangible Book Valueper Share Common Eq
- 16.01
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 3.83
- Cashfrom Investing Activities
- 0.14
- Cashfrom Financing Activities
- -3.08
- Net Changein Cash
- 0.88
- Period
- 2024-12-31
- Total Revenue
- 12.72
- Selling/ General/ Admin Expenses Total
- 1.02
- Depreciation/ Amortization
- 0.32
- Other Operating Expenses Total
- 1.62
- Total Operating Expense
- 12.36
- Operating Income
- 0.36
- Net Income Before Taxes
- 0.13
- Net Income
- 0.09
- Diluted Normalized EPS
- 0.13
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 13.35
- Selling/ General/ Admin Expenses Total
- 1.03
- Depreciation/ Amortization
- 0.31
- Other Operating Expenses Total
- 1.63
- Total Operating Expense
- 13.05
- Operating Income
- 0.3
- Net Income Before Taxes
- 0.08
- Net Income
- 0.05
- Diluted Normalized EPS
- 0.08
- Period
- 2024-09-30
- Total Assets
- 40.47
- Total Liabilities
- 30.2
- Total Equity
- 10.26
- Tangible Book Valueper Share Common Eq
- 15.77
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 4.31
- Cashfrom Investing Activities
- 0.15
- Cashfrom Financing Activities
- -3.97
- Net Changein Cash
- 0.49
- Period
- 2024-06-30
- Total Revenue
- 12.36
- Selling/ General/ Admin Expenses Total
- 1.12
- Depreciation/ Amortization
- 0.32
- Other Operating Expenses Total
- 1.58
- Total Operating Expense
- 12.07
- Operating Income
- 0.3
- Net Income Before Taxes
- 0.07
- Net Income
- 0.04
- Diluted Normalized EPS
- 0.06
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 15.33
- Selling/ General/ Admin Expenses Total
- 1.11
- Depreciation/ Amortization
- 0.33
- Other Operating Expenses Total
- 2.36
- Total Operating Expense
- 14.89
- Operating Income
- 0.43
- Net Income Before Taxes
- 0.21
- Net Income
- 0.15
- Diluted Normalized EPS
- 0.24
- Period
- 2024-03-31
- Total Assets
- 40.26
- Total Liabilities
- 30.14
- Total Equity
- 10.12
- Tangible Book Valueper Share Common Eq
- 15.55
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -9.06
- Cashfrom Investing Activities
- 0.11
- Cashfrom Financing Activities
- 8.24
- Net Changein Cash
- -0.71
- Period
- 2023-12-31
- Total Revenue
- 15.6
- Selling/ General/ Admin Expenses Total
- 1.18
- Depreciation/ Amortization
- 0.32
- Other Operating Expenses Total
- 2.08
- Total Operating Expense
- 15.23
- Operating Income
- 0.37
- Net Income Before Taxes
- 0.15
- Net Income
- 0.11
- Diluted Normalized EPS
- 0.18
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Zenlabs Ethica Technical
Moving Average
SMA
- 5 Day32.34
- 10 Day31.99
- 20 Day32.22
- 50 Day31.85
- 100 Day34.33
- 300 Day37.76
Zenlabs Ethica Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Makers Laboratories
- 165.35
- 27.3
- 19.78
- 230
- 114
- 97.59
- Ind Swift
- 15.12
- 0.4
- 2.72
- 34.49
- 12
- 82.57
- Zenlabs Ethica
- 32.84
- 0.04
- 0.12
- 52.1
- 27.33
- 21.38
- Patron Exim
- 6.79
- 0
- 0
- 9.8
- 4.8
- 15.74
- Muller And Phipps India
- 229.35
- -4.65
- -1.99
- 726.2
- 215.75
- 14.34
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Makers Laboratories
- -
- 1.29
- -2.32
- 1.31
- Ind Swift
- 4.29
- -
- -
- -1.44
- Zenlabs Ethica
- 80
- 2.05
- 6.1
- 0.94
- Patron Exim
- 22.03
- 0.4
- -
- -
- Muller And Phipps India
- 44.33
- -
- -
- 17.89
Zenlabs Ethica Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 12-May-25
- Audited Results
- 07-Feb-25
- Quarterly Results
- 12-Nov-24
- Quarterly Results
- 07-Aug-24
- Quarterly Results
- 20-May-24
- Audited Results
- 29-Jan-24
- Quarterly Results
- 06-Nov-23
- Quarterly Results
- 28-Jul-23
- Quarterly Results
- 24-May-23
- Audited Results
- 09-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 30-Sept-24
- 04-Sept-24
- AGM
- 30-Sept-23
- 04-Sept-23
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 20-Jul-22
- 01-Aug-22
- 29-Jul-22
- 0.25


